News
International News
Education
Environment
Healthcare
Technology
Internet
Science
Social and Non-Profit
Local News
Politicsand Policy
Government
Politics
Local Government
International Policy
Businessand Economy
Economy
Finance
Financial Markets
Jobs and Labor
Company News
Industry News
Aerospace
Agriculture
Chemicals
Commodities
Construction and Engineering
Consumer Electronics
Defense
Energy
Nuclear Energy
Oil and Gas
Renewable Energy
Financial Services
Banking
Insurance
Fishing and Aquaculture
Manufacturing
Information Technology
Metals and Mining
Pharmaceuticals and Biotechnology
Real Estate
Professional and Business Services
Legal
Telecommunications
Tobacco
Retail
Transportation
Air Transportation
Maritime Transportation
Rail Transportation
Road Transportation
Utilities
Forestry and Wood Industry
Artsand Culture
Art
Books and Literature
Entertainment
Cinema
Media
Radio and Television
Music
Lifestyleand Leisure
Automotive
Home and Garden
Fashion and Luxury
Textile and Apparel
Food
Travel and Hospitality
Boating and Yachting
Sports
Baseball
Basketball
Boxing
Cricket
Cycling
Football (American)
Football (Australian)
Football (Soccer)
Golf
Hockey
Racing
Rugby
Sailing
Skiing and Winter Sports
Tennis
Volleyball
The security settings of your browser are blocking the execution of scripts.
To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.
If you have changed your browser's security settings, you can click here.
Onco-Innovations Ltd.
Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board
-5d
Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation of Its PNKP Inhibitor Technology
7/11
Onco-Innovations Strengthens Clinical Leadership with Appointment of Dr. Islam Mohamed as Advisory Board Chair
7/10
Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials
7/4
Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors' Conference Call
7/2
Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium
6/27
Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025
6/25
Inka Health Co-Founders Publish New Study Advancing Real-World Applicability of Lung Cancer Clinical Trial Outcomes
6/20
Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers
6/13
Onco-Innovations' Inka Health to Launch Global AI-Oncology Consortium to Advance Predictive Cancer Research
6/5